Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 12.00M | $55.0M | 14.97% | +53.3K | 2026-06-30 |
| BlackRock, Inc. | 8.72M | $40.0M | 10.87% | +284.6K | 2026-06-30 |
| BML Capital Management, LLC | 6.95M | $32.0M | 8.67% | -106.3K | 2026-06-30 |
| Tang Capital Management LLC | 4.81M | $22.0M | 6.00% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 2.96M | $13.0M | 3.70% | -281.3K | 2026-06-30 |
| Bain Capital Life Sciences Investors, LLC | 2.08M | $9.0M | 2.59% | -285.0K | 2026-06-30 |
| Geode Capital Management, LLC | 1.96M | $9.0M | 2.44% | +210.7K | 2026-06-30 |
| State Street Corp | 1.65M | $7.0M | 2.06% | -42.2K | 2026-06-30 |
| Two Sigma Investments, LP | 1.51M | $7.0M | 1.88% | -- | 2026-06-30 |
| Dimensional Fund Advisors LP | 1.30M | $6.0M | 1.62% | +44.0K | 2026-06-30 |
